Records containing: Hemophilia B
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2021-01-22Evaluation of Joint Arthropathy Using Ultrasound Technique in Children With Severe Hemophilia Undergoing Prophylaxis Regimen
-
CLINICAL_TRIALS study record update · 2021-01-06A Study Comparing Factor Level and Inhibitor Titer Testing Results Drawn From Central Venous Lines and Venipuncture
-
CLINICAL_TRIALS study record update · 2020-12-19A Phase 1 Single-ascending and Multiple-ascending Dose, Safety, Tolerability and Pharmacokinetics Study of Subcutaneously Administered ALN-AT3SC in Healthy Adult Volunteers and Hemophilia A or B Patients (Moderate or Severe Hemophilia)
-
CLINICAL_TRIALS study record update · 2020-12-19A Phase I/IIa Safety and Pharmacokinetic Study of Intravenous FIXFc in Previously Treated Hemophilia B Patients
-
CLINICAL_TRIALS study record update · 2020-12-19A Global, Multicenter, Observational Study Evaluating the Impact of rFVIIIFc and rFIXFc on Patient-reported Treatment Burden and Health Economic Outcomes
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2020-11-10A Phase 1, Open-label, Multi-center, Dose-escalation Study to Investigate the Safety, Pharmacokinetics and Pharmacodynamics of ISU304 in Previously Treated Hemophilia B Patients
-
CLINICAL_TRIALS study record update · 2020-07-31An Open-Label, Multicenter Evaluation of the Safety and Efficacy of Recombinant Coagulation Factor IX Fc Fusion Protein (rFIXFc; BIIB029) in the Prevention and Treatment of Bleeding in Previously Untreated Patients With Severe Hemophilia B
-
CLINICAL_TRIALS study record update · 2020-06-16A Phase 2a Study of Ataluren (PTC124) as an Oral Treatment for Nonsense-Mutation-Mediated Hemophilia A and B
-
CLINICAL_TRIALS study record update · 2020-05-19Gene Therapy, Open-label, Dose-escalation Study of PF-06838435 (SPK-9001) [Adeno-associated Viral Vector With Human Factor IX Gene] in Subjects With Hemophilia B
-
CLINICAL_TRIALS study record update · 2020-05-15A Long-Term Follow-Up Study in Subjects With Sever Hemophilia B Who Received Adeno-Associated Viral Vectors Expressing Human Factor IX
-
CLINICAL_TRIALS study record update · 2020-02-13Ultrasonography in Hemophilic Joint Disease
-
CLINICAL_TRIALS study record update · 2019-07-11Gait Evaluation in Haemophiliac Patients
-
CLINICAL_TRIALS study record update · 2019-05-20UNDERSTANDING HEMOPHILIA A AND B DRUG DOSAGE ADMINISTRATION PATTERNS
-
CLINICAL_TRIALS study record update · 2019-05-10Discrepancy Between Factor IX Level and Bleeding Phenotype
-
CLINICAL_TRIALS study record update · 2019-05-03TREATMENT PATTERNS AND OUTCOMES IN PATIENTS TREATED WITH BENEFIX OR REFACTO/REFACTO AF - A SWEDISH COHORT STUDY
-
CLINICAL_TRIALS study record update · 2019-04-11Study of Recombinant Factor IX Product, IB1001, in Previously Treated Pediatric Subjects With Hemophilia B
-
CLINICAL_TRIALS study record update · 2019-03-12A Phase 1 Safety Study in Subjects With Severe Hemophilia B (Factor IX Deficiency) Using a Single-Stranded, Adeno-Associated Pseudotype 8 Viral Vector to Deliver the Gene for Human Factor IX
-
CLINICAL_TRIALS study record update · 2018-11-14Phase I/II Open-Label Safety and Dose Finding Study of Adeno-Associated Virus (AAV) rh10-Mediated Gene Transfer of Human Factor IX in Adults With Moderate/Severe to Severe Hemophilia B
-
CLINICAL_TRIALS study record update · 2018-10-18A Phase 1, First in Man, Multicenter, Open Label, Single Escalating Dose Study of BAY1093884 in Subjects With Severe Hemophilia Types A or B, With or Without Inhibitors
-
CLINICAL_TRIALS study record update · 2018-09-24Pharmacovigilance Evaluation Of Benefix (Registered) In Germany And Austria
-
CLINICAL_TRIALS study record update · 2018-09-10BAX 326 (Recombinant Factor IX): Evaluation of Safety, Immunogenicity, and Hemostatic Efficacy in Previously Treated Patients With Severe (FIX Level < 1%) or Moderately Severe (FIX Level <= 2%) Hemophilia B - A Continuation Study
-
CLINICAL_TRIALS study record update · 2018-09-10Phase I/II/III Pharmacokinetic and Outcome Study of Recombinant Factor IX Product, IB1001, in Subjects With Hemophilia B
-
CLINICAL_TRIALS study record update · 2018-09-04Evaluation of Real World Outcomes With Extended Half-Life Concentrates for Routine Clinical Use in Haemophilia A and B: UK - EHL Outcomes Registry
-
CLINICAL_TRIALS study record update · 2018-06-06Comparing the Burden of Illness of Hemophilia in the Developing and the Developed World: The Sao Paulo - Toronto Hemophilia Study
-
CLINICAL_TRIALS study record update · 2018-04-25A Feasibility and Usability Study of a Nursing Orchestrated, Customized 3 Dimensional Virtual Reality Environment in Children With Hemophilia Undergoing Routine Intravenous Procedures